| Update 2011: leflunomide in rheumatoid arthritis–strengths and weaknesses F Behrens, M Koehm, H Burkhardt Current opinion in rheumatology 23 (3), 282-287, 2011 | 97 | 2011 |
| Rare loss-of-function mutation in SERPINA3 in generalized pustular psoriasis S Frey, H Sticht, D Wilsmann-Theis, A Gerschütz, K Wolf, S Löhr, ... The Journal of investigative dermatology 140 (7), 1451-1455. e13, 2020 | 60 | 2020 |
| Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis F Behrens, M Koehm, D Thaçi, H Gnann, G Greger, B Maria Wittig, ... Rheumatology 55 (10), 1791-1795, 2016 | 43 | 2016 |
| Does concomitant methotrexate with adalimumab influence treatment outcomes in patients with psoriatic arthritis? Data from a large observational study F Behrens, M Koehm, U Arndt, BM Wittig, G Greger, D Thaçi, ... The Journal of rheumatology 43 (3), 632-639, 2016 | 41 | 2016 |
| Development and validation of a new Disease Activity Score in 28 joints–based treatment response criterion for rheumatoid arthritis F Behrens, HP Tony, R Alten, S Kleinert, EC Scharbatke, M Köhm, ... Arthritis Care & Research 65 (10), 1608-1616, 2013 | 33 | 2013 |
| Influence of ethanol on the pharmacokinetics of methylphenidate’s metabolites ritalinic acid and ethylphenidate K Michaela, FK Gerold, WT Stefan Arzneimittelforschung 60 (05), 238-244, 2010 | 32 | 2010 |
| Increased Serum Levels of the IL‐33 Neutralizing sST 2 in Limited Cutaneous Systemic Sclerosis A Wagner, M Köhm, A Nordin, E Svenungsson, JM Pfeilschifter, ... Scandinavian Journal of Immunology 82 (3), 269-274, 2015 | 30 | 2015 |
| Anti-TNFα-therapy as an evidence-based treatment option for different clinical manifestations of psoriatic arthritis M Köhm, H Burkhardt, F Behrens Clin Exp Rheumatol 33 (Suppl 5), S109-S114, 2015 | 23 | 2015 |
| Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research A Sens, S Rischke, L Hahnefeld, E Dorochow, SMG Schäfer, D Thomas, ... Journal of Mass Spectrometry and Advances in the Clinical lab 28, 35-46, 2023 | 20 | 2023 |
| The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies N Hunzelmann, G Riemekasten, MO Becker, P Moinzadeh, A Kreuter, ... British Journal of Dermatology 174 (6), 1384-1387, 2016 | 20 | 2016 |
| Use of a “critical difference” statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid … F Behrens, M Koehm, EC Schwaneck, M Schmalzing, H Gnann, G Greger, ... BMC rheumatology 3, 1-9, 2019 | 17 | 2019 |
| Dual-Energy CT in patients with suspected gouty arthritis:: Effects on treatment regimen and clinical outcome SC Metzger, M Koehm, JL Wichmann, S Buettner, JE Scholtz, M Beeres, ... Academic Radiology 23 (3), 267-272, 2016 | 17 | 2016 |
| Omics and multi-omics analysis for the early identification and improved outcome of patients with psoriatic arthritis R Gurke, A Bendes, J Bowes, M Koehm, RM Twyman, A Barton, ... Biomedicines 10 (10), 2387, 2022 | 14 | 2022 |
| Innovative imaging technique for visualization of vascularization and established methods for detection of musculoskeletal inflammation in psoriasis patients M Köhm, L Zerweck, PH Ngyuen, H Burkhardt, F Behrens Frontiers in medicine 7, 468, 2020 | 14 | 2020 |
| Association of improvement in pain with therapeutic response as determined by individual improvement criteria in patients with rheumatoid arthritis EC Scharbatke, F Behrens, M Schmalzing, M Koehm, G Greger, H Gnann, ... Arthritis Care & Research 68 (11), 1607-1615, 2016 | 14 | 2016 |
| Metabolic profiling in rheumatoid arthritis, psoriatic arthritis, and psoriasis: elucidating pathogenesis, improving diagnosis, and monitoring disease activity E Dorochow, M Köhm, L Hahnefeld, R Gurke Journal of Personalized Medicine 12 (6), 924, 2022 | 13 | 2022 |
| Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups G Assmann, M Köhm, V Schuster, F Behrens, R Mössner, N Magnolo, ... BMC Medical Genetics 21, 1-7, 2020 | 13 | 2020 |
| Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumab S Mojtahed Poor, T Ulshöfer, LA Gabriel, M Henke, M Köhm, F Behrens, ... Clinical & Experimental Immunology 196 (2), 259-275, 2019 | 13 | 2019 |
| Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study) F Behrens, M Koehm, T Rossmanith, R Alten, M Aringer, M Backhaus, ... Rheumatology 60 (11), 5318-5328, 2021 | 12 | 2021 |
| Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis from European scleroderma trials and research AM Hoffmann-Vold, C Brunborg, P Airò, LP Ananyeva, L Czirják, ... Chest 163 (3), 586-598, 2023 | 9 | 2023 |
David SimonFriedrich-Alexander University在 uk-erlangen.de 的电子邮件经过验证
David SimonFriedrich-Alexander University在 uk-erlangen.de 的电子邮件经过验证
Stefan W. ToennesInstitute of Legal Medicine, University Hospital, Frankfurt在 em.uni-frankfurt.de 的电子邮件经过验证